Trending...
- Billboard, Music Week, and DJ Times Charting Recording Artist, NOAH, Releases Groundbreaking Single "BABYMAKER"
- Mayor Wu and City of Boston Celebrate Immigrant Heritage Month
- Massachusetts: MCSW Announces Keynote Speakers for Historic 25th Anniversary Gala
We Decode is proud to announce that our "We Decode DNA Kit" has been named one of the top 50 most innovative products of 2023 by Innovation & Tech Today (I&TT)
CHURCHTON, Md. - BostonChron -- We Decode is proud to announce that our "We Decode DNA Kit" has been named one of the top 50 most innovative products of 2023 by Innovation & Tech Today (I&TT). I&TT, a leading publishers of content on innovation, technology, and the sciences announced the winners of its Top 50 Most Innovative Products competition. The Top 50 Most Innovative Products is I&TT's most popular feature every year. The feature includes a collection of business innovations, new products, and connected services, along with gadgets from industries such as healthcare, smart home, outdoor and adventure, STEM, gaming, and entertainment.
The "We Decode DNA Kit" is a revolutionary product that makes it easy for anyone to decode their own DNA from the comfort of their own home. It includes everything needed to collect a saliva sample and send it off for analysis, as well as detailed instructions and access to an online portal where users can view their results. The kit also includes interactive educational tools that help users understand the implications of their results and how they can use them in their everyday lives.
More on Boston Chron
"We are thrilled to have our DNA Kit recognized by Innovation & Tech Today," said Cherissa Jackson, CEO of We Decode. "Our mission is to empower individuals to make optimal health decisions based on comprehensive genomics screenings that successfully predict, inform and then match interested individuals to optimal products based on their genetics make up."
To learn more about the We Decode DNA Kit or purchase one today, visit https://wedecode.me/product/dna-testing-kit/ today.
The "We Decode DNA Kit" is a revolutionary product that makes it easy for anyone to decode their own DNA from the comfort of their own home. It includes everything needed to collect a saliva sample and send it off for analysis, as well as detailed instructions and access to an online portal where users can view their results. The kit also includes interactive educational tools that help users understand the implications of their results and how they can use them in their everyday lives.
More on Boston Chron
- Bahamas to Host the 2023 Caribbean Masters' Track and Field Championship Labor Day Weekend
- ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress
- Research Urges Standardization of FDA's Human Factors Engineering Practices Within the Medical Device Industry
- City of Boston Opens Applications for Nightlife Initiative for a Thriving Economy Committee
- Family Eyecare Solutions Introduces New Technology RightEye's EyeQ Vision Test
"We are thrilled to have our DNA Kit recognized by Innovation & Tech Today," said Cherissa Jackson, CEO of We Decode. "Our mission is to empower individuals to make optimal health decisions based on comprehensive genomics screenings that successfully predict, inform and then match interested individuals to optimal products based on their genetics make up."
To learn more about the We Decode DNA Kit or purchase one today, visit https://wedecode.me/product/dna-testing-kit/ today.
Source: We Decode
Filed Under: Health
0 Comments
Latest on Boston Chron
- Boston: LinkedInsights: Abigail Milewski
- Smart Cities of the Future by Vine Strategy
- Tom Olen Memorial Fund Awards Scholarship to a Norwood High School Senior
- Electives named 'Corporate Learning Solution of the Year' by EdTech Breakthrough
- Syros to Present at Sidoti June 2023 Virtual Small-Cap Conference
- The Data Economics Company and Gordian Knot Strategies Highlight Deployment of Enkrateia Platform for More Strategic Investments in U.S. Forests
- Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma
- Strivve partners with innovative Reseda Group
- RevBio krijgt 2 miljoen dollar subsidie om de ontwikkeling van zijn nieuwe implantaatproduct voor de tandheelkundige hechting van botfragmenten te bevorderen
- Hanover Crossing Welcomes Twelve Tesla Superchargers
- RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
- Timing is Key: Discover the Advantages of Selling Now, Backed by Experts
- Governor Healey Re-Nominates Dr. Charlene Bonner to Massachusetts Parole Board
- Life Sciences Workforce Initiative Launched for Boston Residents
- Spring is in bloom with our May partners!
- Get Ready for Fireworks in Sexy Red, White, and Blue Bustier Babydoll Lingerie
- Pacific Program Management Promotes Guy Faretra to National Director, Delivery Services
- Financial IT Launches Fintech Pathfinder: Showcasing the Most Promising Fintech Startups
- Wágner Resurfaces with Second Single "I Ran" After 30-Year Hiatus
- Author/Photographer David Goodman Announces June 27 Release of His New Book An American Cannabis Story